What Researchers Did
The author reviewed laboratory and clinical research on how low oxygen levels in tumours affect radiation treatment of cervical cancer, and on the strategies tried to overcome it.
What They Found
This review of laboratory and clinical information found that the importance of tumour hypoxia to radiation control of cervical cancer is difficult to quantify, because inherent radiosensitivity, reoxygenation, repair and cell proliferation are all interrelated. Clinical data supporting the beneficial effects of blood transfusion, erythropoietin and perfluorochemicals were inconclusive. The review notes that extrapolation from animal data suggests raising hemoglobin levels in anaemic patients before radiotherapy may be useful. No benefit was shown for patients with cervical cancer treated with hypoxic cell radiation sensitizers alongside radiation.
What This Means for Canadian Patients
The abstract says the possible benefits of hyperbaric oxygen combined with hypofractionated radiation are discussed. It does not report results, a protocol, or a conclusion about whether hyperbaric oxygen helps. Patients with cervical cancer should talk with their radiation oncology team about any oxygen-related strategy, since the abstract describes the evidence for the other approaches it reviews as inconclusive or showing no benefit.
Canadian Relevance
The study is marked as having a Canadian connection. The abstract itself does not give further detail.
Study Limitations
This is a narrative review rather than a new trial, and the abstract states that the clinical evidence for the strategies it covers is inconclusive.